Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Sell

C

Aptevo Therapeutics Inc (APVO)

Pharmaceutical Preparations

https://www.aptevotherapeutics.com

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

2401 4TH AVE., SUITE 1050
SEATTLE, WA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/20/2016

Market Cap

3,996,171

Shares Outstanding

22,330,000

Weighted SO

22,333,796

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

KRON --.--%

CYCN --.--%

LRMR --.--%

ADXN --.--%

ACHL --.--%

NTRB --.--%

QNRX --.--%

LGVN --.--%

Beta

5.1860

Last Div

0.0000

Range

0.285-21.648

Chg

-0.0108

Avg Vol

5998001

Mkt Cap

3996171

Exch

NASDAQ

Country

US

Phone

206 838 0500

DCF Diff

2.2550

DCF

2.2550

Div Yield

0.0000

P/S

4.4303

EV Multiple

-0.0374

P/FV

0.3346

Div Yield %

0.0000

P/E

-0.0598

PEG

0.0005

Payout

-0.0003

Current Ratio

1.7677

Quick Ratio

1.7677

Cash Ratio

1.4885

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

3127.6147

CCC

-3127.6147

Gross Margin

0.5166

Op Margin

-28.7716

Pretax Margin

-27.9900

Net Margin

-27.6652

Eff Tax Rate

0.0027

ROA

-1.6724

ROE

-2.6614

ROCE

-2.7312

NI/EBT

0.9884

EBT/EBIT

0.9728

EBIT/Rev

-28.7716

Debt Ratio

0.3368

D/E

1.1259

LT Debt/Cap

0.5296

Total Debt/Cap

0.5296

Int Coverage

-2.7081

CF/Debt

-4.8352

Equity Multi

3.3433

Rec Turnover

0.0000

Pay Turnover

0.1167

Inv Turnover

0.0000

FA Turnover

0.1689

Asset Turnover

0.0605

OCF/Share

-6.9028

FCF/Share

-6.9028

Cash/Share

2.2916

OCF/Sales

-26.9368

FCF/OCF

1.0000

CF Coverage

-4.8352

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

-3037.1250

P/BV

0.3346

P/B

0.3346

P/S

4.4303

P/E

-0.0598

P/FCF

-0.1645

P/OCF

-0.0615

P/CF

-0.0615

PEG

0.0005

P/S

4.4303

EV Multiple

-0.0374

P/FV

0.3346

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation